| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/26/2004 | WO2003095474A3 Peptides and methods for the control of obesity |
| 02/26/2004 | WO2003089590A3 TRANSIENT AND/OR PERMANENT MODIFICATION OF SEXUAL BEHAVIOR AND/OR FERTILITY USING RECOMBINANT CHIMERIC GnRH |
| 02/26/2004 | WO2003056299A3 Labeling reagent and methods of use |
| 02/26/2004 | WO2003049684A3 Pseudo-antibody constructs |
| 02/26/2004 | WO2003046568A3 Protein biopolymer markers indicative of a disease state |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2002074808A3 Modified insulin with reduced immunogenicity |
| 02/26/2004 | WO2002074793A3 Novel peptides for the diagnosis of schizophrenia |
| 02/26/2004 | WO2002053172A3 Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover |
| 02/26/2004 | WO2002038796A3 Methods for determining protease cleavage site motifs |
| 02/26/2004 | US20040039179 Lithography; ink jet printing; for drug delivery |
| 02/26/2004 | US20040039178 Metal chelate-labelled peptides |
| 02/26/2004 | US20040039159 By addition of hydrophobic moiety to active portion of allatostatin peptides analogs are produced which exhibit overall amphiphilic nature and are capable of penetrating insect cuticle while still retaining biological activity |
| 02/26/2004 | US20040039158 Display long emission wavelengths, long decay times, high quantum yields; covalently linked or associated pairs with long life resonance energy transfer donor, ruthenium-ligand complex, and long wavelength acceptor, Texas Red |
| 02/26/2004 | US20040038906 Endothelin antagonist |
| 02/26/2004 | US20040038903 Gonadotropin releasing hormone antagonists in gel-forming concentration |
| 02/26/2004 | US20040038902 For therapy of neoplastic disease |
| 02/26/2004 | US20040038897 Stimulates a sexual and/or erectile response in a mammal |
| 02/26/2004 | US20040038430 Monoclonal antibodies specific for PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 02/26/2004 | US20040038268 Support bound probes and methods of analysis using the same |
| 02/26/2004 | US20040037775 Treating and preventing autoimmune diseases. The compositions and methods utilize peptides that are cell-specific. The peptides are conjugated to drugs. The peptide-drug conjugate can be internalized by the targeted cells thereby allowing for |
| 02/26/2004 | DE10225139A1 Verfahren zur Identifizierung von immunreaktiven Peptiden A method for identifying immunoreactive peptides |
| 02/25/2004 | EP1391729A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof |
| 02/25/2004 | EP1390755A2 Assay to determine efficacy of treatment for mycobacterial infection |
| 02/25/2004 | EP1390521A1 Glycopeptide antibiotics |
| 02/25/2004 | EP1390495A2 Immunostimulatory oligodeoxynucleic molecules |
| 02/25/2004 | EP1390494A2 Method for stabilising of nucleic acids |
| 02/25/2004 | EP1390406A2 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 02/25/2004 | EP1390405A2 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390392A1 Methods to inhibit viral replication |
| 02/25/2004 | EP1390056A2 Glycopeptide antibiotics |
| 02/25/2004 | EP0751957B1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 02/24/2004 | US6696559 Antimicrobial peptides and methods of use |
| 02/24/2004 | US6696545 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 02/24/2004 | US6696412 Purification of daptomycin by binding to ion exchange resins in the presence of buffers and chaotropic agents, then eluting and recovering; peptide antibiotics |
| 02/24/2004 | US6696408 Administering glycosylated polypeptides as antiepileptics and anticonvulsants or for prophylaxis of psychological disorders |
| 02/24/2004 | US6696274 Polypeptides capable of crossing the small intestine or blood brain barrier; bioavailability |
| 02/24/2004 | US6696061 Binds human major histocompatibility complex (mhc) class ii allotype |
| 02/24/2004 | CA2102036C Vaccines raising an immunological response against the disease caused by the iowa strain of porcine reproductive and respiratory syndrome virus |
| 02/19/2004 | WO2004015392A2 Improved method to identify targeting molecules |
| 02/19/2004 | WO2004015070A2 Isolation and identification of t cells |
| 02/19/2004 | WO2004014940A2 PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR ß PROTEINS |
| 02/19/2004 | WO2004014879A1 New process |
| 02/19/2004 | WO2004014415A1 Growth hormone releasing peptides |
| 02/19/2004 | WO2003099857B1 Antagonistic peptides of prostaglandin e2 receptor subtype ep4 |
| 02/19/2004 | WO2003064460A3 Two gonadotropin releasing hormones and a method to isolate the same |
| 02/19/2004 | WO2003059255A3 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/19/2004 | WO2003046571A3 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease |
| 02/19/2004 | WO2003045974A3 Methods and compositions for derepression of iap-inhibited caspase |
| 02/19/2004 | WO2003008537A9 Epitope sequences |
| 02/19/2004 | WO2002094778A3 Peptide conjugates and fluorescence detection methods for intracellular caspase assay |
| 02/19/2004 | WO2002072614A8 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 02/19/2004 | WO2002066498A3 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 02/19/2004 | WO2002064160A3 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 02/19/2004 | WO2002028888A3 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 02/19/2004 | US20040034201 Enhanced affinity hyaluronan binding peptides |
| 02/19/2004 | US20040033940 Cyclic hepta-peptide derivative from colonial ascidians, lissoclinum SP |
| 02/19/2004 | US20040033534 Using peptide mimetics to prevent binding and gene expression activation by phosphorylated aspartyl regulatory protein; decreasing development of antibiotic resistance in pathogenic bacteria; gene expression inhibition |
| 02/19/2004 | US20040033235 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 02/19/2004 | US20040031696 Descaling stainless steels by immersing in electrolytic cells containing electrolytes solutions comprising sulfuric, hydrofluoric, phosphoric and/or hydrochloric acid, then passing electricity |
| 02/19/2004 | CA2759572A1 Isolation and identification of t cells |
| 02/19/2004 | CA2495222A1 Peptides as solubilizing excipients for transforming growth factor ss proteins |
| 02/19/2004 | CA2494551A1 Improved method to identify targeting molecules |
| 02/18/2004 | EP1389126A1 Retrocyclins: antiviral and antimicrobial peptides |
| 02/18/2004 | EP1089755B1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 02/18/2004 | EP0734264B1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 02/18/2004 | EP0731838B1 Binding structures directed against the ca55.1 antigen |
| 02/18/2004 | EP0728012B1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 02/18/2004 | EP0720482B1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 02/18/2004 | CN1476480A Isolated peptides which bind to HLA-C molecules and uses thereof |
| 02/18/2004 | CN1476476A Ligand/receptor specificity exchangers that redirect antibodies to receptors on pathogen |
| 02/17/2004 | US6693168 Chiral cyanoamines and methods of preparation |
| 02/17/2004 | US6693165 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 02/17/2004 | US6693081 Bone stimulating factor |
| 02/17/2004 | US6693079 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6693078 Insulin-like growth factor agonist molecules |
| 02/17/2004 | US6692907 Conserved motif of hepatitis C virus E2/NS1 region |
| 02/17/2004 | US6692747 Peptide for use in the treatment of infections, viral and cancer diseases |
| 02/12/2004 | WO2004013161A2 Peptide aggregates |
| 02/12/2004 | WO2003089456A3 Peptide inhibitors of protein kinase c |
| 02/12/2004 | WO2003087824A3 Charge-balanced chemoselective linkers |
| 02/12/2004 | WO2003040094A3 Methods for preparation of macrocyclic molecules macrocyclic molecules prepared thereby and substrates and solid supports for use therein |
| 02/12/2004 | WO2003033526A3 Synthesis of cyclosporin analogs |
| 02/12/2004 | WO2003031589A8 Peptides and related compounds having thrombopoietic activity |
| 02/12/2004 | WO2003014698A3 Biological assay detection method |
| 02/12/2004 | WO2002068461A3 Heterocarpine, a human ghrh-binding protein |
| 02/12/2004 | US20040029809 Spheron components useful in determining compounds capable of treating symptoms of Alzheimer's disease, and treatments and animal models produced therefrom |
| 02/12/2004 | US20040029808 Binding antibody to estradiol; test device |
| 02/12/2004 | US20040029782 Antiinflammatory agents; osteoporosis; cardiovascular disorders; coating for prosthetics |
| 02/12/2004 | US20040029781 Purification of fusion proteins; immobilization |
| 02/12/2004 | US20040029778 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery |
| 02/12/2004 | US20040029281 Carrier vectors through an epithelium with tight junctions |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029182 For diagnosis/therapy of colorectal cancer |
| 02/12/2004 | US20040029115 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously |
| 02/11/2004 | EP1387854A2 Sfrp and peptide motifs that interact with sfrp and methods of their use |
| 02/11/2004 | EP1387660A1 Use of 3-position cyclosporin derivatives for hair growth |
| 02/11/2004 | EP1176987B1 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics |